Biomerica (NASDAQ:BMRA) Shares Cross Below Two Hundred Day Moving Average – Here’s Why

Shares of Biomerica, Inc. (NASDAQ:BMRAGet Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.47 and traded as low as $0.30. Biomerica shares last traded at $0.33, with a volume of 59,303 shares changing hands.

Biomerica Stock Performance

The stock has a market capitalization of $5.55 million, a P/E ratio of -0.89 and a beta of -1.11. The business has a 50-day moving average price of $0.35 and a 200 day moving average price of $0.47.

Biomerica (NASDAQ:BMRAGet Free Report) last released its earnings results on Tuesday, October 15th. The company reported ($0.08) EPS for the quarter. Biomerica had a negative return on equity of 69.21% and a negative net margin of 110.44%. The company had revenue of $1.81 million during the quarter.

Institutional Trading of Biomerica

Several institutional investors have recently bought and sold shares of the company. Russell Investments Group Ltd. lifted its stake in shares of Biomerica by 11.8% in the first quarter. Russell Investments Group Ltd. now owns 225,435 shares of the company’s stock worth $188,000 after buying an additional 23,872 shares in the last quarter. Fore Capital LLC raised its holdings in Biomerica by 72.1% in the 1st quarter. Fore Capital LLC now owns 59,680 shares of the company’s stock worth $50,000 after acquiring an additional 25,000 shares during the last quarter. Finally, Perritt Capital Management Inc bought a new position in Biomerica in the 2nd quarter valued at approximately $31,000. 22.28% of the stock is owned by hedge funds and other institutional investors.

Biomerica Company Profile

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Read More

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.